13-51944145-G-T

Variant summary

Our verdict is Pathogenic. The variant received 21 ACMG points: 21P and 0B. PS3PM1PM5PP2PP3_StrongPP5_Very_Strong

The NM_000053.4(ATP7B):​c.3207C>A​(p.His1069Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000944 in 1,614,166 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000052016: The most pronounced variant effect results in <10% of normal nucleotide binding activity (e.g., Morgan_2004). PMID:17717039, 10544227, 11690702, 15205462, 24897373, 21334398" and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H1069R) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.00093 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00094 ( 1 hom. )

Consequence

ATP7B
NM_000053.4 missense

Scores

13
5
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:40O:3

Conservation

PhyloP100: 2.73

Publications

308 publications found
Variant links:
Genes affected
ATP7B (HGNC:870): (ATPase copper transporting beta) This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019]
ATP7B Gene-Disease associations (from GenCC):
  • Wilson disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000053.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 21 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000052016: The most pronounced variant effect results in <10% of normal nucleotide binding activity (e.g., Morgan_2004). PMID: 17717039, 10544227, 11690702, 15205462, 24897373, 21334398; SCV000602583: Functional studies indicate that the variant protein has altered subcellular localization (Payne 1998, van den Berghe 2009), reduced affinity to ATP (Morgan 2004, Rodriguez-Granillo 2008) and reduced half-life (Payne 1998). Cells expressing the variant protein show reduced viability when exposed to increased levels of copper (Payne 1998). PMID: 9724794; SCV000626851: Experimental studies have shown that this missense change affects ATP7B function (PMID: 9724794, 19937698, 22240481, 24909901).; SCV000967653: "In vitro functional studies provide some evidence that the p.His1069Gln variant may result in reduced ATP7B protein expression (van den Berghe 2009)"; SCV001142439: Functional studies demonstrate that p.His1069Gln had a very low activity compared to wildtype (PMID: 22240481), resulted in reduced ATP7B protein expression (PMID: 19937698), and caused subcellular mislocalization (PMID: 24909901).; SCV002051776: Functional studies demonstrate that this substitution results in mislocalization and increased degradation of the ATP7B protein in cells.; SCV002767518: Functional studies of mutant protein disrupts intracellar copper balance and reduced protein stability (Huster D. et al. (2003), Rodriguez-Granillo, A., et al. (2008)).; SCV003920292: In vivo and In vitro functional studies suggest that this variant reduces ATP binding and is retained in the endoplasmic reticulum (Morgan 2004 PMID:15205462, Mercer 2017 PMID:28119449, Parisi 2018 PMID:29674751).; SCV004361971: Functional studies have shown that this variant results in reduced ATP7B protein expression, subcellular mislocalization of the ATP7B protein to the endoplasmic reticulum where it undergoes rapid degradation, and partial loss of copper export activity (PMID: 8298641, 9654149, 9724794, 10051024, 12557139, 17717039, 18692069, 19937698, 21398519, 22240481, 22692182, 24253677, 24909901, 28119449, 29674751, 30026388).; SCV004845404: Functional studies have shown that this variant results in reduced ATP7B protein expression, subcellular mislocalization of the ATP7B protein to the endoplasmic reticulum where it undergoes rapid degradation, and partial loss of copper export activity (PMID: 8298641, 9654149, 9724794, 10051024, 12557139, 17717039, 18692069, 19937698, 21398519, 22240481, 22692182, 24253677, 24909901, 28119449, 29674751, 30026388).; SCV000329091: Published functional studies show the H1069Q variant has significantly reduced ATP binding affinity and reduced protein stability, leading to impaired copper transport (Dmitriev et al., 2011; Morgan et al., 2004; Rodriguez-Granillo et al., 2008; Chesi et al., 2016);; SCV001247795: PS3:Moderate; SCV004026153: PS3; SCV002610410: Based on several functional studies, this mutation affects ATP binding, protein dynamics, and chemical and thermal stabilities relative to wild type (Rodriguez-Granillo, 2008; Dmitriev, 2011; Morgan, 2004).
PM1
In a hotspot region, there are 11 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 12 uncertain in NM_000053.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr13-51944146-T-C is described in ClinVar as Pathogenic. ClinVar VariationId is 1069926.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 198 curated pathogenic missense variants (we use a threshold of 10). The gene has 32 curated benign missense variants. Gene score misZ: -0.88091 (below the threshold of 3.09). Trascript score misZ: 0.82063 (below the threshold of 3.09). GenCC associations: The gene is linked to Wilson disease.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.948
PP5
Variant 13-51944145-G-T is Pathogenic according to our data. Variant chr13-51944145-G-T is described in ClinVar as Pathogenic. ClinVar VariationId is 3848.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000053.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP7B
NM_000053.4
MANE Select
c.3207C>Ap.His1069Gln
missense
Exon 14 of 21NP_000044.2P35670-1
ATP7B
NM_001406511.1
c.3207C>Ap.His1069Gln
missense
Exon 15 of 22NP_001393440.1P35670-1
ATP7B
NM_001406512.1
c.3207C>Ap.His1069Gln
missense
Exon 15 of 22NP_001393441.1P35670-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP7B
ENST00000242839.10
TSL:1 MANE Select
c.3207C>Ap.His1069Gln
missense
Exon 14 of 21ENSP00000242839.5P35670-1
ATP7B
ENST00000634844.1
TSL:1
c.3063C>Ap.His1021Gln
missense
Exon 14 of 21ENSP00000489398.1B7ZLR4
ATP7B
ENST00000418097.7
TSL:1
c.3012C>Ap.His1004Gln
missense
Exon 13 of 20ENSP00000393343.2F5H748

Frequencies

GnomAD3 genomes
AF:
0.000933
AC:
142
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00374
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00168
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000922
AC:
230
AN:
249392
AF XY:
0.000850
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000464
Gnomad ASJ exome
AF:
0.00536
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000418
Gnomad NFE exome
AF:
0.00128
Gnomad OTH exome
AF:
0.000990
GnomAD4 exome
AF:
0.000945
AC:
1381
AN:
1461864
Hom.:
1
Cov.:
31
AF XY:
0.000956
AC XY:
695
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.000447
AC:
20
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00547
AC:
143
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.000468
AC:
25
AN:
53396
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00102
AC:
1135
AN:
1112010
Other (OTH)
AF:
0.000944
AC:
57
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
93
186
278
371
464
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000932
AC:
142
AN:
152302
Hom.:
0
Cov.:
32
AF XY:
0.000806
AC XY:
60
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41566
American (AMR)
AF:
0.000327
AC:
5
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00374
AC:
13
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00168
AC:
114
AN:
68020
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00125
Hom.:
0
Bravo
AF:
0.000910
EpiCase
AF:
0.00104
EpiControl
AF:
0.00154

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
30
-
-
Wilson disease (33)
9
-
-
not provided (9)
1
-
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Pathogenic
0.54
CADD
Benign
23
DANN
Benign
0.97
DEOGEN2
Pathogenic
0.97
D
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.91
D
MetaRNN
Pathogenic
0.95
D
MetaSVM
Pathogenic
0.93
D
MutationAssessor
Pathogenic
3.9
H
PhyloP100
2.7
PrimateAI
Uncertain
0.68
T
PROVEAN
Pathogenic
-7.5
D
REVEL
Pathogenic
0.91
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Varity_R
0.95
gMVP
0.92
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs76151636;
hg19: chr13-52518281;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.